Societe Generale S.A.:企業のM&A・事業提携・投資動向

◆英語タイトル:Societe Generale S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1500
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Societe Generale S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Societe Generale S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Societe Generale S.A. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Societe Generale S.A.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Societe Generale S.A.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Societe Generale S.A.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Societe Generale S.A. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Societe Generale S.A.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Societe Generale S.A.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 13
Corporate Venturing – Overview 13
Corporate Venturing – Deal reports 14
CAPITAL RAISING 90
Capital Raising – Overview 90
Capital Raising – Deal reports 91
DIVESTMENTS 106
Divestments – Overview 106
Divestments – Deal reports 107
APPENDIX 114
Contact Us 114
About MarketLine Financial Deals Database 114
Deal Definition and Methodology 116
About MarketLine 123

List of Tables
Table 1: Societe Generale SA M&A volume and value trend (2014-YTD2018)
Table 2: Societe Generale SA M&A activity by geography (2014-YTD2018)
Table 3: Societe Generale SA corporate venturing volume and value trend (2014-YTD2018)
Table 4: Societe Generale SA corporate venturing by geography (2014-YTD2018)
Table 5: Societe Generale SA capital raising volume and value trend (2014-YTD2018)
Table 6: Societe Generale SA capital raising by deal type (2014-YTD2018)
Table 7: Societe Generale SA divestments volume and value trend (2014-YTD2018)
Table 8: Societe Generale SA divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Societe Generale SA M&A volume and value trend (2014-YTD2018)
Figure 2: Societe Generale SA M&A activity by geography (2014-YTD2018)
Figure 3: Societe Generale SA corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Societe Generale SA corporate venturing by geography (2014-YTD2018)
Figure 5: Societe Generale SA capital raising volume and value trend (2014-YTD2018)
Figure 6: Societe Generale SA capital raising by deal type (2014-YTD2018)
Figure 7: Societe Generale SA divestments volume and value trend (2014-YTD2018)
Figure 8: Societe Generale SA divestments by geography (2014-YTD2018)

★海外企業調査レポート[Societe Generale S.A.:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Comerica Incorporated:企業の戦略・SWOT・財務情報
    Comerica Incorporated - Strategy, SWOT and Corporate Finance Report Summary Comerica Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DAIS Corp (DLYT):企業の財務・戦略的SWOT分析
    Summary Dais Corps (Dais) is an alternative energy company. It provides industry changing and nano technology based applications. The company's products include ultra capacitors, clean water systems, heating and cooling equipment, among others. It also provides NanoAir, NanoCap, ConsERV and NanoClea …
  • FibroStatin SL:製薬・医療:M&Aディール及び事業提携情報
    Summary FibroStatin SL (FibroStatin) is a drug development company that focuses on the development of treatment candidates for drug resistant lung cancer and idiopathic pulmonary fibrosis. The company’s pipeline products include T12/FST12 for NSCLC, GPBP-Mab/FSM26 for idiopathic pulmonary fibrosis a …
  • Mobidiag Ltd:企業の製品パイプライン分析
    Summary Mobidiag Ltd (Mobidiag) operates as a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products portfolio includes Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screeni …
  • Banque Degroof Petercam Private Banking:企業の戦略・SWOT・財務情報
    Banque Degroof Petercam Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Degroof Petercam Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Groupama S.A.:企業の戦略・SWOT・財務情報
    Groupama S.A. - Strategy, SWOT and Corporate Finance Report Summary Groupama S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Encore Wire Corporation:企業の戦略・SWOT・財務情報
    Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report Summary Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Veolia Environnement SA (VIE):企業の財務・戦略的SWOT分析
    Veolia Environnement SA (VIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Ernst & Young Global Ltd:戦略・SWOT・企業財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • UNIQA Bulgaria:企業の戦略・SWOT・財務情報
    UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report Summary UNIQA Bulgaria - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • Advance Syntex Limited:企業の戦略的SWOT分析
    Advance Syntex Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • HITT Contracting Inc:企業の戦略的SWOT分析
    HITT Contracting Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Tesson Holdings limited:戦略・SWOT・企業財務分析
    Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report Summary Tesson Holdings limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Paddy Power Betfair Plc
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • New Image Group Ltd:企業の戦略的SWOT分析
    New Image Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Oceania Cruises, Inc.:企業の戦略・SWOT・財務分析
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • China Gezhouba Group Co Ltd (600068):企業の財務・戦略的SWOT分析
    China Gezhouba Group Co Ltd (600068) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • aap Implantate AG (AAQ):医療機器:M&Aディール及び事業提携情報
    Summary aap Implantate AG (aap Implantate) is a medical device company, which develops, manufactures and markets trauma products and biomaterials for orthopedic treatment. Its products include locked plating systems for anatomical reduction, cannulated screws, standard plates and screws for osteosyn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆